Published • loading... • Updated
Link Between NAION and Ozempic, Wegovy Will Be Focus of Early Discovery in GLP-1 Vision Loss Lawsuits
Summary by aboutlawsuits.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Link Between NAION and Ozempic, Wegovy Will Be Focus of Early Discovery in GLP-1 Vision Loss Lawsuits
Court has directed lawyers to focus early discovery on certain “cross cutting” issues likely to impact all of the Ozempic and Wegovy NAION lawsuits, including evidence establishing GLP-1 drugs can cause the vision loss claimed. The U.S. District Judge presiding over all federal Wegovy and Ozempic NAION lawsuits has directed the parties to focus early di…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
